This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Congenital absence, atresia and stenosis of small intestine
Q17_CONGEN_ABSENCE_ATRES_STENO_SMALL_INTESTINE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
48 |
4. Check minimum number of eventsNone |
48 |
5. Include endpointsNone |
48 |
6. Filter based on genotype QC (FinnGen only) |
44 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO_DIGES_SYSTEM1
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q3[8-9]|Q4[0-5]
- Name in latin
- Agenesis, atresia sive stenosis congenita intestini tenuis
Similar endpoints
↥List of similar endpoints to
Congenital absence, atresia and stenosis of small intestine
based on the number of shared cases.
Similar with more cases:
- Other congenital malformations of the digestive system
- Other congenital malformations of the digestive system, including avohilmo
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities, including avohilmo
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 712 | 399 | 312 |
| Only index persons | 450 | 249 | 201 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 0.06 | 0.01 | 0.01 |
| Only index persons | 0.37 | 0.53 | 0.16 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 44 | 33 | 11 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 5.76 | 6.41 | 3.81 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
9
5
21.96
6.56
14.7
2.2
19.22
31.60
umol/l
—
9
5
10
8
15.63
6.44
12.4
1.8
1.26
1.58
umol/l
—
10
8
12
15
10.49
6.33
12.2
2.4
28.77
2.91
umol/l
—
12
10
9
6
18.29
6.19
5.3
13.0
—
—
—
0
0
28
122
4.55
5.64
23.6
5.5
35.66
36.89
g/l
0.48
28
117
9
9
12.15
5.30
1.6
1.9
—
—
—
0
0
8
8
11.84
4.73
5.8
3.8
3.19
5.71
u/ml
—
8
8
16
52
4.25
4.63
23.4
4.9
6.00
5.13
umol/l
0.24
16
44
12
27
5.69
4.33
17.9
15.9
1.04
1.10
mg/l
0.21
12
27
16
57
3.83
4.03
10.9
4.6
29.50
29.46
s
0.01
16
57
9
18
5.97
3.58
2.3
1.7
—
141.03
—
0
7
10
23
5.29
3.56
15.0
5.7
229.50
156.00
%
—
10
23
19
83
3.26
3.44
5.9
3.1
2.60
0.99
e6/l
0.35
14
36
8
15
6.24
3.36
2.1
2.2
—
—
—
0
0
9
20
5.35
3.32
16.2
8.3
2.59
3.00
g/l
—
9
20
18
78
3.20
3.28
5.9
3.1
8.31
1.90
e6/l
0.60
13
32
20
93
3.10
3.23
7.9
2.2
—
—
—
0
0
30
176
3.20
3.22
7.1
3.0
—
—
estimate
—
0
0
11
33
4.08
3.07
18.5
3.5
46.91
48.74
ng/l
0.08
11
28
6
9
7.48
2.96
1.3
1.3
—
—
—
0
0
34
221
3.35
2.94
19.4
6.1
143.32
105.75
u/l
1.04
34
212
19
91
2.91
2.86
5.5
2.4
50.84
53.20
u/l
0.13
19
85
10
31
3.85
2.72
15.0
6.9
106.70
85.52
%
—
10
31
7
15
5.32
2.71
36.1
4.5
60.73
48.95
%
—
7
15
17
79
2.87
2.67
56.3
11.9
24.72
24.59
mmol/l
0.06
17
79
14
59
3.01
2.60
19.3
7.8
23.36
22.90
mmol/l
0.30
14
59
16
74
2.82
2.52
27.1
6.4
1.33
1.40
mmol/l
0.44
16
69
26
155
2.65
2.49
13.2
2.4
72.50
69.03
nmol/l
0.36
26
140
7
17
4.67
2.47
1.1
1.1
—
—
—
0
0
5
8
6.85
2.43
1.8
2.8
—
—
—
0
0
23
131
2.58
2.39
12.7
3.3
—
—
—
0
0
20
109
2.52
2.25
3.9
1.5
96.28
100.69
pmol/l
0.13
12
55
28
181
2.49
2.16
50.1
8.5
1.23
1.23
mmol/l
0.13
28
166
9
32
3.26
2.14
2.6
4.7
213.67
263.38
u/l
—
9
32
20
112
2.43
2.10
19.4
3.6
37.90
31.85
u/l
0.43
20
106
14
67
2.59
2.02
36.9
7.3
24.16
24.14
mmol/l
0.01
14
67
6
19
3.48
1.72
2.8
1.6
—
—
—
0
0
6
19
3.48
1.72
5.5
14.3
1.05
1.04
%
—
6
19
14
72
2.38
1.72
34.7
7.0
9.86
9.28
kpa
0.60
14
72
6
21
3.13
1.56
32.5
22.9
24.67
24.87
mmol/l
—
6
21
6
22
2.98
1.48
32.5
22.1
0.58
0.65
%
—
6
22
6
23
2.85
1.41
32.5
21.4
0.78
0.96
%
—
6
23
6
23
2.85
1.41
2.3
1.9
—
—
—
0
0
14
78
2.16
1.41
37.6
7.7
5.21
5.09
kpa
0.31
14
78
14
78
2.16
1.41
37.5
7.3
0.49
0.89
mmol/l
0.24
14
59
10
48
2.40
1.40
24.1
12.8
104.60
106.08
mmol/l
—
10
48
6
24
2.72
1.35
1.8
2.2
—
—
—
0
0
24
166
1.97
1.35
59.2
10.8
1.24
1.23
mmol/l
0.20
24
158
6
26
2.50
1.23
2.8
2.7
430.83
141.42
ng/l
—
6
26
28
218
1.77
0.97
21.3
7.8
5.80
5.89
mmol/l
0.13
28
199
6
29
2.23
0.93
32.5
17.3
15.22
15.26
kpa
—
6
29
6
29
2.23
0.93
32.5
17.3
5.27
5.28
kpa
—
6
29
6
31
2.07
0.88
32.5
16.4
0.40
0.63
mmol/l
—
6
26
5
24
2.21
0.77
33.4
10.8
118.20
123.13
g/l
—
5
24
13
177
0.62
0.66
2.7
1.9
—
—
—
0
0
6
36
1.76
0.59
1.7
2.3
6.58
13.28
iu/l
—
6
29
7
45
1.65
0.52
2.3
1.9
—
—
—
0
0
7
47
1.58
0.50
2.4
1.8
—
—
—
0
0
8
56
1.52
0.46
2.7
1.9
—
—
—
0
0
8
56
1.52
0.46
3.5
4.9
545.88
754.53
ng/l
—
8
50
9
65
1.48
0.42
1.2
1.9
—
—
—
0
0
0
16
0.00
0.42
0.0
1.1
—
—
—
0
0
0
16
0.00
0.42
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
38
354
1.52
0.37
4.0
4.1
—
—
—
0
0
39
367
1.53
0.29
50.9
14.4
13.90
13.17
%
1.98
39
362
10
123
0.76
0.25
2.4
2.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
8.34
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
28
258
1.23
0.19
9.4
3.5
6.43
8.15
mm/h
0.74
28
239
7
85
0.79
0.16
1.4
1.6
—
—
—
0
0
11
97
1.18
0.10
6.1
3.3
1.02
1.02
kg/l
0.00
11
61
9
84
1.09
0.07
1.7
2.0
—
—
—
0
0
9
86
1.06
0.07
3.3
2.5
164.33
282.01
u/l
—
9
86
13
129
1.01
0.00
2.4
2.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
108.83
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
1.64
—
0
5
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
2.58
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
6.44
—
0
5
0
6
0.00
-0.00
0.0
1.3
—
43.79
—
0
6
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
0.11
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
3.10
—
0
5
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.36
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
4.08
—
0
5
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_ABSENCE_ATRES_STENO_SMALL_INTESTINE and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_ABSENCE_ATRES_STENO_SMALL_INTESTINE.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_ABSENCE_ATRES_STENO_SMALL_INTESTINE – Congenital absence, atresia and stenosis of small intestine
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data